Adherence with Topical Glaucoma Medication Monitored Electronically. The Travatan Dosing Aid Study

Ophthalmology

Volumn 116, Issue 2, 2009, Pages 191-199

  Okeke, Constance O ^a   Quigley, Harry A ^b,c   Jampel, Henry D ^b   Ying, Gui shuang ^a   Plyler, Ryan J ^b   Jiang, Yuzhen ^d   Friedman, David S ^b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TRAVOPROST;

ADULT; AGED; ANAMNESIS; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COHORT ANALYSIS; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSING AID; DRUG MONITORING; DRUG USE; ELECTRONICS; FEMALE; GLAUCOMA; HEALTH BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OBSERVATIONAL STUDY; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT MONITORING; PHYSICIAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SINGLE BLIND PROCEDURE; TECHNICAL AID; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; ATTITUDE TO HEALTH; CLOPROSTENOL; COHORT STUDIES; DRUG MONITORING; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, ANGLE-CLOSURE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; QUESTIONNAIRES;

EID: 58849131406     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2008.09.004     Document Type: Article

References (39)

1. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130 (2000) 429-440
2. Heijl A., Leske M.C., Bengtsson B., et al., Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 120 (2002) 1268-1279
3. Anderson D.R. Collaborative normal tension glaucoma study. Curr Opin Ophthalmol 14 (2003) 86-90
4. Kass M.A., Heuer D.K., Higginbotham E.J., et al., Ocular Hypertension Treatment Study Group. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120 (2002) 701-713
5. Lichter P.R., Musch D.C., Gillespie B.W., et al., CIGTS Study Group. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 108 (2001) 1943-1953
6. Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT) and Glaucoma Laser Trial follow-up study: 7. Results. Am J Ophthalmol 120 (1995) 718-731
7. Friedman D.S., Nordstrom B.L., Mozaffari E., and Quigley H.A. Glaucoma management among individuals enrolled in a single comprehensive insurance plan. Ophthalmology 112 (2005) 1500-1504
8. Friedman D.S., Quigley H.A., Gelb L., et al. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS). Invest Ophthalmol Vis Sci 48 (2007) 5052-5057
9. Nordstrom B.L., Friedman D.S., Mozaffari E., et al. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol 140 (2005) 598-606
10. LaFleur J., and Oderda G.M. Methods to measure patient compliance with medication regimens. J Pain Palliat Care Pharmacother 18 (2004) 81-87
11. Osterberg L., and Blaschke T. Adherence to medication. N Engl J Med 353 (2005) 487-497
12. Norell S.E. Monitoring compliance with pilocarpine therapy. Am J Ophthalmol 92 (1981) 727-731
13. Kass M.A., Meltzer D.W., Gordon M., et al. Compliance with topical pilocarpine treatment. Am J Ophthalmol 101 (1986) 515-523
14. Kass M.A., Gordon M., Morley Jr. R.E., et al. Compliance with topical timolol treatment. Am J Ophthalmol 103 (1987) 188-193
15. Wang P.S., Benner J.S., Glynn R.J., et al. How well do patients report noncompliance with antihypertensive medications?. A comparison of self-report versus filled prescriptions. Pharmacoepidemiol Drug Saf 13 (2004) 11-19
16. Choo P.W., Rand C.S., Inui T.S., et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 37 (1999) 846-857
17. Byerly M., Fisher R., Whatley K., et al. A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. Psychiatry Res 133 (2005) 129-133
18. Vriesendorp R., Cohen A., Kristanto P., et al. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana. Eur J Clin Pharmacol 63 (2007) 1115-1121
19. Parker C.S., Chen Z., Price M., et al. Adherence to warfarin assessed by electronic pill caps, clinician assessment, and patient reports: results from the IN-RANGE study. J Gen Intern Med 22 (2007) 1254-1259
20. Robin A.L., Novack G.D., Covert D.W., et al. Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use. Am J Ophthalmol 144 (2007) 533-540
21. Wetzels G.E., Nelemans P.J., Schouten J.S., et al. All that glisters is not gold: a comparison of electronic monitoring versus filled prescriptions-an observational study. BMC Health Serv Res [serial online] 6 (2006) 8. http://www.biomedcentral.com/1472-6963/6/8 Accessed July 25, 2008
22. McHorney C.A., Ware Jr. J.E., and Raczek A.E. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 31 (1993) 247-263
23. Ross C.E., and Mirowsky J. Components of depressed mood in married men and women: the Center for Epidemiologic Studies' Depression Scale. Am J Epidemiol 119 (1984) 997-1004
24. Feldman S.R., Camacho F.T., Krejci-Manwaring J., et al. Adherence to topical therapy increases around the time of office visits. J Am Acad Dermatol 57 (2007) 81-83
25. Stewart W.C., Konstas A.G., and Pfeiffer N. Patient and ophthalmologist attitudes concerning compliance and dosing in glaucoma treatment. J Ocul Pharmacol Ther 20 (2004) 461-469
26. Buchan J.C., Siddiqui S., and Gilmour D. Once daily drop regimes help reduce involuntary non-compliance [letter]. Graefes Arch Clin Exp Ophthalmol 245 (2007) 327-328
27. Buller A.J., Morgan L.H., and Hercules B.L. Patients prefer once-daily glaucoma drops. Graefes Arch Clin Exp Ophthalmol 245 (2007) 293-294
28. Nordstrom B.L., Friedman D.S., Mozaffari E., et al. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol 140 (2005) 598-606
29. Jampel H.D., Schwartz G.F., Robin A.L., et al. Patient preferences for eye drop characteristics: a willingness-to-pay analysis. Arch Ophthalmol 121 (2003) 540-546
30. Friedman D.S., Jampel H.D., Congdon N.G., et al. The TRAVATAN Dosing Aid accurately records when drops are taken. Am J Ophthalmol 143 (2007) 699-701
31. Rotchford A.P., and Murphy K.M. Compliance with timolol treatment in glaucoma. Eye 12 (1998) 234-236
32. Patel P.C., and Spaeth G.L. Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg 26 (1995) 233-236
33. Olthoff C.M., Schouten J.S., van de Borne B.W., and Webers C.A. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension: an evidence-based review. Ophthalmology 112 (2005) 953-961
34. Schwartz G.F., Reardon G., and Mozaffari E. Persistency with latanoprost or timolol in primary open-angle glaucoma suspects. Am J Ophthalmol 137 suppl (2004) S13-S16
35. Farmer K.C. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 21 (1999) 1074-1090
36. De Amici D., Klersy C., Ramajoli F., et al. Impact of the Hawthorne effect in a longitudinal clinical study: the case of anesthesia. Control Clin Trials 21 (2000) 103-114
37. Wagner G.J., and Ghosh-Dastidar B. Electronic monitoring: adherence assessment or intervention?. HIV Clin Trials 3 (2002) 45-51
38. Kass M.A., Gordon M., and Meltzer D.W. Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy?. Am J Ophthalmol 101 (1986) 524-530
39. Rand C.S., and Sevick M.A. Ethics in adherence promotion and monitoring. Control Clin Trials 21 suppl (2000) 241S-247S